Article
Pulmonary deposition of inhaled tobramycin prior to and after respiratory therapy and use of inhaled albuterol in cystic fibrosis patients colonized with Pseudomonas aeruginosa.
Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia - 1 Jan 2009
Grotta Milena Baptistella, Etchebere Elba Cristina de Sá Camargo, Ribeiro Antonio Fernando, Romanato Juliana, Ribeiro Maria Angela Gonçalves de Oliveira, Ribeiro José Dirceu
Abstract excerpt
OBJECTIVE: To evaluate whether respiratory therapy followed by the use of inhaled albuterol modifies the pulmonary deposition of inhaled tobramycin in patients with cystic fibrosis (CF) and whether pulmonary deposition correlates with disease severity or genotype. METHODS: A prospective study was carried out including patients with CF older than 6 years of age and colonized with Pseudomonas aeruginosa. Exclusion...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.